Jianxin Bao
Co-Founder & Chief Executive Officer Gateway Biotechnology Inc.
Seminars
Wednesday 20th May 2026
GW-TT2: Achieving Reliable Nasal Delivery of Hydrophobic Drugs Through Formulation–Device Alignment
4:00 pm
- Explore the impact of various formulation attributes on CNS and inner ear targeting
- Understand challenges in low-dose delivery and strategies to prevent underdosing
- Case study examples from a unique nasal formulation and delivery relief to recent onset tinnitus
